Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$34.73 - $43.33 $158,229 - $197,411
4,556 Added 23.89%
23,623 $969,000
Q1 2023

May 09, 2023

BUY
$33.58 - $41.2 $15,614 - $19,158
465 Added 2.5%
19,067 $681,000
Q4 2022

Jan 20, 2023

SELL
$37.12 - $46.52 $244,880 - $306,892
-6,597 Reduced 26.18%
18,602 $0
Q3 2022

Nov 03, 2022

BUY
$36.54 - $48.66 $58,610 - $78,050
1,604 Added 6.8%
25,199 $1.12 Million
Q2 2022

Aug 04, 2022

BUY
$31.71 - $43.0 $140,602 - $190,662
4,434 Added 23.14%
23,595 $874,000
Q1 2022

Apr 27, 2022

BUY
$29.88 - $37.04 $17,420 - $21,594
583 Added 3.14%
19,161 $710,000
Q4 2021

Jan 31, 2022

SELL
$25.61 - $35.1 $37,262 - $51,070
-1,455 Reduced 7.26%
18,578 $565,000
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $4,896 - $5,920
146 Added 0.73%
20,033 $672,000
Q2 2021

Aug 09, 2021

SELL
$34.54 - $47.25 $228,723 - $312,889
-6,622 Reduced 24.98%
19,887 $793,000
Q1 2021

May 10, 2021

BUY
$42.51 - $63.78 $282,011 - $423,116
6,634 Added 33.38%
26,509 $1.19 Million
Q4 2020

Feb 04, 2021

SELL
$45.3 - $60.27 $29,943 - $39,838
-661 Reduced 3.22%
19,875 $1.12 Million
Q3 2020

Oct 19, 2020

SELL
$47.45 - $62.95 $3,890 - $5,161
-82 Reduced 0.4%
20,536 $974,000
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $56,641 - $73,809
-1,209 Reduced 5.54%
20,618 $1.22 Million
Q1 2020

May 06, 2020

SELL
$41.6 - $63.4 $32,780 - $49,959
-788 Reduced 3.48%
21,827 $1.03 Million
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $40,818 - $49,474
-758 Reduced 3.24%
22,615 $1.37 Million
Q3 2019

Nov 05, 2019

SELL
$59.06 - $72.15 $59,060 - $72,150
-1,000 Reduced 4.1%
23,373 $1.4 Million
Q2 2019

Aug 20, 2019

BUY
$62.09 - $86.14 $16,515 - $22,913
266 Added 1.1%
24,373 $1.57 Million
Q1 2019

May 14, 2019

BUY
$52.92 - $81.17 $1.28 Million - $1.96 Million
24,107 New
24,107 $1.96 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.